These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation. Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954 [TBL] [Abstract][Full Text] [Related]
11. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. Salavert-Lletí M; Zaragoza-Crespo R Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284 [TBL] [Abstract][Full Text] [Related]
12. Antifungal prophylaxis in bone marrow transplant. Lam HH; Althaus BL Ann Pharmacother; 1995 Sep; 29(9):921-4. PubMed ID: 8547742 [TBL] [Abstract][Full Text] [Related]
13. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. Playford EG; Webster AC; Sorrell TC; Craig JC J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344 [TBL] [Abstract][Full Text] [Related]
14. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Uzun O; Anaissie EJ Blood; 1995 Sep; 86(6):2063-72. PubMed ID: 7662953 [No Abstract] [Full Text] [Related]
15. Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. MacMillan ML; Goodman JL; DeFor TE; Weisdorf DJ Am J Med; 2002 Apr; 112(5):369-79. PubMed ID: 11904111 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799 [TBL] [Abstract][Full Text] [Related]
17. Antifungal prophylaxis in immunocompromised hosts. Reents S; Goodwin SD; Singh V Ann Pharmacother; 1993 Jan; 27(1):53-60. PubMed ID: 8431623 [TBL] [Abstract][Full Text] [Related]
18. Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: a cost-minimization analysis. Wakerly L; Craig AM; Malek M; Hoffmeyer U; Lloyd A; Valette F; Phillips R; Zabihollah M J Hosp Infect; 1996 May; 33(1):35-48. PubMed ID: 8738200 [TBL] [Abstract][Full Text] [Related]
20. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group. Denning DW; Donnelly JP; Hellreigel KP; Ito J; Martino P; van't Wout JW Chemotherapy; 1992; 38 Suppl 1():43-9. PubMed ID: 1611930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]